News > ICMR decides to exclude Molnupiravir drug from Covid treatment guidelines
ICMR decides to exclude Molnupiravir drug from Covid treatment guidelines
The Hindu | 12/01/2022 09:33 AM | Click to read full article
The ICMR’s National Task Force for COVID-19 has decided against including antiviral drug molnupiravir in the Clinical Management Protocol for COVID-19 as of now, official sources said on Tuesday.
The experts of the task force cited safety concerns and argued that Molnupiravir was not of much benefit in COVID treatment. Molnupiravir is an antiviral drug that inhibits SARS-CoV-2 replication by viral mutagenesis.
